19-407437-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001136263.2(C2CD4C):c.925G>C(p.Val309Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000765 in 1,491,158 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136263.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151986Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000995 AC: 9AN: 90432Hom.: 0 AF XY: 0.000103 AC XY: 5AN XY: 48644
GnomAD4 exome AF: 0.0000754 AC: 101AN: 1339064Hom.: 2 Cov.: 31 AF XY: 0.0000913 AC XY: 60AN XY: 657266
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152094Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.925G>C (p.V309L) alteration is located in exon 2 (coding exon 1) of the C2CD4C gene. This alteration results from a G to C substitution at nucleotide position 925, causing the valine (V) at amino acid position 309 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at